Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fruet

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Transfusion Medicine (Oxford, England)|March 1, 1997
A new tool in white blood cell reduction for packed red cells: 5 log depletionA Bontadini, F Fruet, R Conte
Transfusion Medicine (Oxford, England)|October 8, 1997
Process control of filtered red blood cells: which counting method?R Conte, A Bontadini, D Cirillo, et al.
Pathologica|May 1, 1985
[New trends in hormone therapy]F Pannuti, P Ferrari, F Fruet, et al.
Cancer Treatment Reports|August 1, 1979
New regimen of combination chemotherapy (CHVV) in the treatment of advanced bladder cancer: a pilot studyF Pannuti, A Martoni, M Casadio, et al.
Cancer Treatment Reports|November 1, 1984
4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancerA Martoni, L Tomasi, G Farabegoli, et al.
Lancet (London, England)|March 11, 2000
Allergy to latexG Bandini, M Stanzani, F Bonifazi, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patientsF Pannuti, A Martoni, G Cilenti, et al.
Cancer Treatment Reports|May 1, 1979
New polychemotherapy regimen for head and neck tumors: pilot studyF Pannuti, A Cricca, F Fruet, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1984
A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III studyF Pannuti, G Iafelice, A Martoni, et al.
Transfusion|June 1, 1994
Comparative analysis of six different white cell-reduction filters for packed red cellsA Bontadini, F Fruet, P L Tazzari, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Transfusion Medicine (Oxford, England)|March 1, 1997
A new tool in white blood cell reduction for packed red cells: 5 log depletionA Bontadini, F Fruet, R Conte
Transfusion Medicine (Oxford, England)|October 8, 1997
Process control of filtered red blood cells: which counting method?R Conte, A Bontadini, D Cirillo, et al.
Pathologica|May 1, 1985
[New trends in hormone therapy]F Pannuti, P Ferrari, F Fruet, et al.
Cancer Treatment Reports|August 1, 1979
New regimen of combination chemotherapy (CHVV) in the treatment of advanced bladder cancer: a pilot studyF Pannuti, A Martoni, M Casadio, et al.
Cancer Treatment Reports|November 1, 1984
4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancerA Martoni, L Tomasi, G Farabegoli, et al.
Lancet (London, England)|March 11, 2000
Allergy to latexG Bandini, M Stanzani, F Bonifazi, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patientsF Pannuti, A Martoni, G Cilenti, et al.
Cancer Treatment Reports|May 1, 1979
New polychemotherapy regimen for head and neck tumors: pilot studyF Pannuti, A Cricca, F Fruet, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1984
A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III studyF Pannuti, G Iafelice, A Martoni, et al.
Transfusion|June 1, 1994
Comparative analysis of six different white cell-reduction filters for packed red cellsA Bontadini, F Fruet, P L Tazzari, et al.
Pageof 4